IEM Power Systems’ Post

Choosing the right #binders and binding agents during research and development is crucial to maintaining tablet integrity ✅ Pharmaceutical leader Hink Lamain shares more industry insights 🖱️ https://bit.ly/3SVJWQs #Pharma #Ingredients #PharmaceuticalIngredients

Curious about how real-time inlier detection can improve efficiency and quality in pharmaceutical manufacturing? Check out Joseph Andrew's insightful article in BioPharma Asia Magazine to learn how Optimal's synTQ platform is helping manufacturers spot subtle process deviations, prevent drift, and continuously improve production. Read the full article here: https://lnkd.in/exv4ttcz #ProcessAnalyticalTechnology #PharmaceuticalIndustry #DigitalTransformation #SmartManufacturing

A QMM rating system will foster a more robust drug supply chain and greater commitment to quality in pharmaceutical manufacturing. Download the whitepaper today to find out where your organization is on the QMM scale. https://bit.ly/3VR5vEr

Choosing the right #binders and binding agents during research and development is crucial to maintaining tablet integrity ✅ Pharmaceutical leader Hink Lamain shares more industry insights 🖱️ https://bit.ly/3SOR8gZ #Pharma #Ingredients #PharmaceuticalIngredients

Are you ready to elevate your #CIP skid to the next level? Unlock new levels of efficiency, quality, and compliance in pharmaceutical manufacturing! 🌡️🌍 #PumpUpYourCIP #EfficiencyUnleashed #wemakeitworkbetter #wemakeitpumpbetter #SPXFlow

📊 Our LinkedIn poll results are in! 🎉 Thank you to all who participated in sharing your insights on key attributes for selecting pharmaceutical excipients. Link: https://rb.gy/8xheo0 Your input is invaluable! Let's keep the conversation going and stay connected for more engaging polls in the future. Together, we're shaping the future of pharmaceutical formulations! #PollResults #PharmaInsights #StayConnected

Have you read the recently revised ICH Q5A(R2) report? Adopted in November 2023, this report confirms that the pharmaceutical industry is exploring alternate detergents in response to the negative environmental effects attributed to Triton™ X-100. The ban on Triton™ X-100 will not solely affect Europe; rather, it will also significantly impact global pharmaceutical manufacturing. Read more and discover our readily available detergents, Virodex™. https://ow.ly/f6ig30sAmtV

https://lnkd.in/gj-iEi6m i represent my new video regarding the important questions of B.pharmacy first semester pharmaceutical analysis...please watch the video to acquire useful knowledge...and please subscribe to my official YouTube channel to inspire pharma for the latest updates and latest notifications

Have you read the recently revised ICH Q5A(R2) report? Adopted in November 2023, this report confirms that the pharmaceutical industry is exploring alternate detergents in response to the negative environmental effects attributed to Triton™ X-100. The ban on Triton™ X-100 will not solely affect Europe; rather, it will also significantly impact global pharmaceutical manufacturing. Read more and discover our readily available detergents, Virodex™. https://ow.ly/3C4c30sAjuF

Have you read the recently revised ICH Q5A(R2) report? Adopted in November 2023, this report confirms that the pharmaceutical industry is exploring alternate detergents in response to the negative environmental effects attributed to Triton™ X-100. The ban on Triton™ X-100 will not solely affect Europe; rather, it will also significantly impact global pharmaceutical manufacturing. Read more and discover our readily available detergents, Virodex™. https://ow.ly/vCYg30sAfHM